Concepedia

Annemieke Th. den Boer

AT

15

Publications

1.7K

Citations

14

H-Index

1996

Active since

Affiliations

Leiden University Medical Center(Current)

Radboud University Nijmegen

The Netherlands Cancer Institute

Maastricht University

Institute of Haematology and Blood Transfusion

Annemieke Th. den Boer is an author at Leiden University Medical Center specializing in medicine, immunology, and immunotherapy.

Top concepts

Publications per year

1996–2021

15

Publications

15

CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy

Linda Diehl, Annemieke Th. den Boer, Stephen P. Schoenberger et al. · Nature Medicine · 1999 · 457 citations

, , +9

Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity

Bettina Weigelin, Annemieke Th. den Boer, Esther Wagena et al. · Nature Communications · 2021 · 226 citations · Full text

CD40 stimulation leads to effective therapy of CD40<sup>−</sup>tumors through induction of strong systemic cytotoxic T lymphocyte immunity

Geertje J. D. van Mierlo, Annemieke Th. den Boer, Jan Paul Medema et al. · Proceedings of the National Academy of Sciences · 2002 · 220 citations · Full text

Activation of Dendritic Cells That Cross-Present Tumor-Derived Antigen Licenses CD8+ CTL to Cause Tumor Eradication

Geertje J. D. van Mierlo, Zita F. H. M. Boonman, Hélène Dumortier et al. · The Journal of Immunology · 2004 · 167 citations · Full text

Importance of Weight Loss Maintenance and Risk Prediction in the Prevention of Type 2 Diabetes: Analysis of European Diabetes Prevention Study RCT

Linda Penn, Martin White, Jaana Lindström et al. · PLoS ONE · 2013 · 141 citations · Full text

Rows per page

1–5 of 15